Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
06/2003
06/19/2003CA2468266A1 Substituted bicyclic pyrimidinones as a mitotic kinesin ksp inhibitors
06/19/2003CA2468202A1 Assays and implements for determining and modulating hsp90 binding activity
06/19/2003CA2468156A1 Azolopyrimidinone compounds and their use
06/19/2003CA2467916A1 Mitotic kinesin inhibitors
06/19/2003CA2467802A1 Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure
06/19/2003CA2467726A1 Mitotic kinesin inhibitors
06/19/2003CA2467722A1 Thienopyrimidinone derivatives as mitotic kinesin inhibitors
06/19/2003CA2467689A1 Stabilization of hypoxia inducible factor (hif) alpha using inhibitors of hif prolyl hydroxylase
06/19/2003CA2467245A1 Prevention of flap necrosis in plastic surgery
06/19/2003CA2465120A1 Composition and method for treating chronic allograft rejection
06/18/2003EP1319709A1 Disruption of the glutathione S-transferase-omega-1 gene
06/18/2003EP1319410A1 Use of micro-organisms for a directed delivery of substances to specific parts of the gut
06/18/2003EP1319408A1 Remedies for heart failure
06/18/2003EP1319407A1 Pharmaceutical composition for topical treatment of skin disorders and skin wounds
06/18/2003EP1319404A2 Composition for treating and/or prophylaxis of tumors of the breast
06/18/2003EP1319186A1 Prognostic indicator
06/18/2003EP1319184A2 Use of antibodies against specific mhc-peptide complexes
06/18/2003EP1319182A2 G-csf analog compositions and methods
06/18/2003EP1319073A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding them, and uses thereof
06/18/2003EP1319071A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/18/2003EP1319066A2 Isolated human kinase proteins, nucleic acid molecules and uses thereof
06/18/2003EP1319025A2 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse
06/18/2003EP1319015A2 Olfactory and pheromones g-protein coupled receptors
06/18/2003EP1319007A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
06/18/2003EP1319003A1 Xanthine phosphodiesterase v inhibitors
06/18/2003EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors
06/18/2003EP1318995A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
06/18/2003EP1318982A1 Compounds and methods for diagnosing and treating amyloid-related conditions
06/18/2003EP1318981A2 Quinoline and quinazoline derivatives as ligands for the neuropeptide y receptor
06/18/2003EP1318976A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
06/18/2003EP1318840A2 PHOSPHATONIN-RELATED GENE AND i METHODS OF USE THEREOF /i
06/18/2003EP1318839A2 Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation
06/18/2003EP1318837A2 Method of treating estrogen receptor positive carcinoma
06/18/2003EP1318836A2 Treatment of hyperproliferative diseases
06/18/2003EP1318830A2 Notch receptor agonists and uses
06/18/2003EP1318817A1 Use of arginine in the preparation of a medicament for the prevention and treatment of the side effects associated with the intravenous administration of pharmaceuticals
06/18/2003EP1318814A2 Triazole compounds useful as protein kinase inhibitors
06/18/2003EP1318801A2 Topical analgesic compositions containing aliphatic polyamines and methods of using same
06/18/2003EP1318798A1 Water-soluble prodrugs of propofol for treatment of migraine
06/18/2003EP1318794A2 Method for reducing toxicity of combined chemotherapies
06/18/2003EP1171128B1 Combination of n-butyldeoxynojirimycin (nb-dnj) and glycolipid degrading enzymes in therapy
06/18/2003EP1011709A4 Inhibition of apoptotis using prosaposin receptor agonists
06/18/2003EP0981338B1 Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp. infection
06/18/2003CN1425066A Novel stra6 polypeptides
06/18/2003CN1425025A Daptomycin analogs as antibacterial agents
06/18/2003CN1425023A Transgenic mice containing TRP gene disruptions
06/18/2003CN1424926A Synergistic inhibition of viral replication long-chain hydrocarbons and nucleoside analogs
06/18/2003CN1424915A Oral, nasal and pulmonary dosage formulations of copolymer1
06/18/2003CN1424912A Composition comprising camptothecin and pyrimidine derivative for the treatment of cancer
06/18/2003CN1424903A Personal care articles comprising cationic polymer coacervate compositions
06/18/2003CN1424900A Topical skin composition
06/18/2003CN1424396A Preparation of implanting neurons for treating nerve injury diseases
06/17/2003US6579899 Composition for treatment of stress
06/17/2003US6579898 Compositions having improved bioavailability
06/17/2003US6579896 Method for treating allergies using substituted pyrazoles
06/17/2003US6579891 Metal ion chelating agent such as picolinic acid or derivatives; zinc finger protein in a canine lymphoma cell
06/17/2003US6579884 Gastrointestinal inflammatory diseases, antisecretory; infection by Helicobacter pylori of human gastric mucosa; Substituted imidazo(1,2-a)pyridines
06/17/2003US6579877 Combination of benzoquinazoline antifolates and protecting agents
06/17/2003US6579869 Cephalotaxanes: their method of preparation and their use in treatment of cancers, leukemias, parasites, including those resistant to usual chemotherapeutic agents, and as reversal agents
06/17/2003US6579866 Composition and method for modulating nutrient partitioning
06/17/2003US6579863 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
06/17/2003US6579857 Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors
06/17/2003US6579856 Inhibition of stress activated protein kinase (SAPK) pathway and sensitization of cells to cancer therapies
06/17/2003US6579855 Adenovirus-mediated gene therapy
06/17/2003US6579854 Diagnosis and management of infection caused by chlamydia
06/17/2003US6579709 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/17/2003US6579695 Phosphopantetheinyl transferases and uses thereof
06/17/2003US6579689 Modulation of γ-secretase activity
06/17/2003US6579683 A ligand which is a member of Ephrin family of Eph family receptor interactive protein has been shown to be expressed by arterial endothelial cells but not by venous endothelial cell, useful for distinguishing target artieris and veins
06/17/2003US6579544 Blends of vitamins, minerals, carotenoids, flavinoids, glucosamine, chondroitin sulfate, lipoic acid/-A/, coenzyme Q10 and linseed oils for preventing diseases such as degenerative joint disease
06/17/2003US6579541 Oxidative fluorinator compounds as antimicrobials
06/17/2003US6579521 Methods of therapy for HIV infection
06/14/2003CA2412713A1 Dextromethorphan tannate
06/13/2003WO2003047602A1 Immunostimulatory oligodeoxynucleotides
06/13/2003CA2452909A1 Immunostimulatory oligodeoxynucleotides
06/12/2003WO2003048780A2 Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis
06/12/2003WO2003048775A2 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases
06/12/2003WO2003048773A2 Methods for monitoring amyotrophic lateral sclerosis
06/12/2003WO2003048772A2 Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
06/12/2003WO2003048384A2 Methods of identifying genetic risk for and evaluating treatment of alzheimer's disease by determing single nucleotide polymorphisms
06/12/2003WO2003048383A2 Effectors of innate immunity
06/12/2003WO2003048379A1 T-bet compositions and methods of use thereof
06/12/2003WO2003048359A1 Markers for sugar/lipid metabolic disorders and utilization thereof
06/12/2003WO2003048352A2 Histone h3 methyltransferase polypeptide
06/12/2003WO2003048349A2 Acetoacetyl-coa thiolase and use of for the identification of novel fungicidal substances
06/12/2003WO2003048201A1 Antimicrobial bolisin peptides
06/12/2003WO2003048200A1 Nuclear protein 'shoca' - a component of the wnt signalling pathway
06/12/2003WO2003048199A1 Cytotoxic protein and utilization thereof
06/12/2003WO2003048168A2 Trioxane derivatives as antimalaria or anticancer compounds
06/12/2003WO2003048165A1 ADENOSINE A2a RECEPTOR ANTAGONISTS
06/12/2003WO2003048164A2 Adenosine a2a receptor antagonists
06/12/2003WO2003048162A1 Novel crystalline compound
06/12/2003WO2003048140A1 Azole compound and medicinal use thereof
06/12/2003WO2003048137A1 Metabotropic glutamate receptor-5 modulators
06/12/2003WO2003048120A2 2-aryl pyrrologpyrimidines for a1 and a3 receptors
06/12/2003WO2003048116A2 Esters and amides as ppar-alpha agonists ____________
06/12/2003WO2003048109A1 Novel glucagon antagonists
06/12/2003WO2003047697A2 Use of an farsenyl protein tranferase inhibitor in combination with other antineoplastic agents for the manufacture of a medicament against cancer
06/12/2003WO2003047628A1 Combination of an adenosine a2a receptor agonist and an adrenergic beta-2 receptor agonist
06/12/2003WO2003047627A1 Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a thiazolidinedione derivative, and a use thereof for treating diabetes
1 ... 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 ... 1151